4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-004288
Chief Operating Officer sold 3,683 shares at $1.01 ($3,709)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2024-02-12 | Sale | −3,683 | $1.01 | $3,709 | 307,161 | D |
| Open-market sales · 3,683 sh · avg $1.01 · $3,709 | |||||||
Loading xslF345X05/wk-form4_1707776621.xml…